XML 22 R12.htm IDEA: XBRL DOCUMENT
v3.20.2

Stock-Based Compensation | 9 Months Ended
--- | ---
Sep. 30, 2020
Stock-Based Compensation [Abstract] |
Stock-Based Compensation | 4. Stock-Based Compensation No awards were granted during the nine-month period ended September 30, 2020. As of September 30, 2020, there was $51,000 of total unrecognized compensation cost related to non-vested options granted in 2019 under the 2014 Equity Incentive Plan, which will be fully amortized by December 31, 2020. Compensation costs related to stock options amounted to $153,000 and $156,000 during the nine-month periods ended September 30, 2020 and 2019, respectively. A summary of the Company’s stock option activity for the nine-month period ended September 30, 2020 is as follows:
|  |  | Weighted |  |  |  |  |
|  |  | Average Exercise |  | Weighted Average |  | Aggregate
|  |  | Price |  | Remaining |  | Intrinsic Value
| Options |  | Per Share |  | Contractual Term |  | ($000)
Outstanding at January 1, 2020 | 199,825 |  | $ | 24.78 |  | 5.9 | Yrs. |  | $ | 2,823
Granted | — |  |  | — |  | — |  |  |  | —
Exercised | (4,681) |  |  | 17.87 |  | 2.6 | Yrs. |  |  | —
Forfeited | — |  |  | — |  |  |  |  |  | —
Outstanding at September 30, 2020 | 195,144 |  | $ | 24.94 |  | 5.2 | Yrs. |  | $ | 654
Exercisable at September 30, 2020 | 168,394 |  | $ | 23.18 |  | 4.6 | Yrs. |  | $ | 654
Intrinsic value represents the amount by which the market price of the stock on the measurement date exceeded the exercise price of the option. The market price was $24.32 per share as of September 30, 2020 and $38.90 per share as of December 31, 2019. A summary of the Company’s restricted stock activity for the nine-month periods ended September 30, 2020 and 2019 is as follows:
| 2020 |  | 2019
|  |  | Weighted-Average |  |  |  |  | Weighted-Average
| Number of |  | Grant Date |  | Number of |  | Grant Date
| Restricted Stock |  | Fair Value |  | Restricted Stock |  | Fair Value
Non-vested, January 1, | 36,195 |  | $ | 31.65 |  | 34,615 |  | $ | 27.82
Granted | — |  |  | — |  | — |  |  | —
Vested | — |  |  | — |  | — |  |  | —
Forfeited | — |  |  | — |  | — |  |  | —
Non-vested, September 30, | 36,195 |  | $ | 31.65 |  | 34,615 |  | $ | 27.82
The expected future compensation expense relating to the 36,195 shares of non-vested restricted stock outstanding as of September 30, 2020 is $895,000. This cost will be recognized over the remaining vesting period of 4.25 years. Compensation costs related to restricted stock amounted to $250,000 and $217,000 during the nine-month periods ended September 30, 2020 and 2019, respectively.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration